Hjem › Venstreventrikkeldysfunksjon › Ohio
Kliniske studier for Venstreventrikkeldysfunksjon i Ohio
4 studier for Venstreventrikkeldysfunksjon søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Cincinnati Children's Hospital Medical Center ( Site 0034), Cincinnati
- Cleveland Clinic-Cleveland Clinic Chidren's ( Site 0022), Cleveland
RekruttererFase 2/3
29 Days – 17 Years · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital - Cardiology, Columbus
RekruttererFase 3
Opp til 18 år · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital - Cardiology, Columbus
RekruttererFase 3
6 Months – 17 Years · Alle kjønn · Oppdatert 15. jun. 2026 · NCT07188805The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- University Hospitals Cleveland Medical Center, Cleveland
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 28. apr. 2026 · NCT05427370Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.